Kilambi News
Friday, November 20, 2026

Pancreatic cancer pill clears tumours in trial patients

Life Sciences Friday, November 20, 2026 - Updated Nov 20, 2026 06:04

Cancer became undetectable on scans in about one in 12 patients with advanced pancreatic cancer treated with the KRAS inhibitor pill daraxonrasib in a 61 patient trial, with tumours stopped from growing in 90 percent of participants, researchers reported at a cancer conference in Barcelona.

Why it matters: Pancreatic cancer has the lowest survival of any common cancer, and 76.6 percent of trial patients were alive a year after starting treatment against the 40 to 45 percent usually seen with chemotherapy alone, though the drug is unapproved and doctors stress it is not yet a cure.

Data as of The Guardian report of November 20, 2026, read in full via the estate browser route, on trial findings presented by Dr Wungki Park of Memorial Sloan Kettering Cancer Center at the EORTC-NCI-AACR symposium in Barcelona. Single conference presentation, not yet a peer reviewed publication or a regulatory filing; the chemotherapy comparison is the usual outcome cited in the report, not a randomised control arm. Developing item.

In a trial of 61 patients recently diagnosed with advanced pancreatic cancer that had spread to other parts of the body, the KRAS inhibitor pill daraxonrasib left cancer undetectable on CT scans in about one in 12 patients, stopped tumours growing in 90 percent, and shrank or cleared tumours in just over 60 percent, with a median follow-up of 18 months. One year after starting treatment 76.6 percent of patients were alive, against the 40 to 45 percent usually alive a year on chemotherapy alone, and the presenting researcher, Dr Wungki Park of Memorial Sloan Kettering, reported a near doubling in the duration of disease control. Cancer Research UK called the results the biggest leap forward in decades for the disease, while noting that more trials are needed before the treatment can be assessed for routine use and that the pill cannot yet be considered a cure.

Sources

  1. Pill to treat pancreatic cancer hailed as 'biggest breakthrough in decades' - The Guardian - 2026-11-20